Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-02

Clinical Trial Update: Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effectiveness of propranolol for treating post-traumatic stress disorder was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Post-Traumatic Stress Disorder | Phase 4 | Status: TERMINATED | Results posted: 2020-01-02